Normal Movement Restored and New Neurons Formed in Model of Parkinson's Disease STOCKHOLM, Sweden, Nov. 15, 2005 (PRIMEZONE) -- Two weeks of local administration of sNN0031, a compound under development for Parkinson's disease, normalized movement and restored dopamine balance...